Activatable Phototheranostic Materials for Imaging-Guided Cancer Therapy.
Clicks: 252
ID: 65876
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
71.1
/100
248 views
197 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Cancer theranostics that combines diagnostic and therapeutic effects into one entity holds promise in precision medicine. Conventional theranostic agents possess always-on imaging signals and cytotoxicity effects and thus poor selectivity or specificity in cancer treatment. To tackle this issue, activatable phototheranostic materials (PMs) have been developed to simultaneously and specifically turn on their optical imaging (fluorescence/self-luminescence) or photoacoustic signals and photothermal/photodynamic effects in response to cancer hallmarks. This review summarizes the recent progress in the design, synthesis and proof-of-concept applications of activatable PMs. The molecular engineering strategy to increase tumor accumulation and enhance treatment efficacy are highlighted. Current challenges and future perspectives in this emerging field are also discussed.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (111 words).
Try re-searching for a better abstract.
| Reference Key |
cheng2019activatableacs
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Cheng, Penghui;Pu, Kanyi; |
| Journal | ACS applied materials & interfaces |
| Year | 2019 |
| DOI |
10.1021/acsami.9b15064
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.